| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 03/27/2013 | CN102988471A Compound sweet zinc cream used for treating eczema of infant and preparation method thereof |
| 03/27/2013 | CN102988451A Preparation method of sugar-free banlangen granules |
| 03/27/2013 | CN102988434A Centella effective extractive polyethylene glycol ointment and preparation method thereof |
| 03/27/2013 | CN102988429A Pine pollen tablet for preventing alcoholic liver damages |
| 03/27/2013 | CN102988423A Compound ossotide liposome injection |
| 03/27/2013 | CN102988410A Carbomer gel and preparation method thereof |
| 03/27/2013 | CN102988402A Pharmaceutical composition containing adenosine cyclophosphate compound and preparation method of pharmaceutical composition |
| 03/27/2013 | CN102988374A Poly-lactic-co-glycolic acid-polylysine-polyethylene glycol-tetrandrine and daunorubicin copolymer nanoparticles as well as preparation method and application thereof |
| 03/27/2013 | CN102988372A Screening and composition of main auxiliary materials of compound aspirin tablet, and preparation method of compound aspirin sheet |
| 03/27/2013 | CN102988366A Use and nasal administration medicine of hydroxycamptothecine |
| 03/27/2013 | CN102988364A Pharmaceutical composition containing valsartan and amlodipine besylate and preparation method |
| 03/27/2013 | CN102988360A Compound amino acid injection (15HBC) composition |
| 03/27/2013 | CN102988359A Compound amino acid injection (18AA-I) composition |
| 03/27/2013 | CN102988358A Compound amino acid injection (18AA-IV) composition |
| 03/27/2013 | CN102988329A Preparation method and application of yolk antibody microcapsule preparation |
| 03/27/2013 | CN102988328A Method for preparing oral medicine for curing cancer, oral medicine for curing cancer and application thereof |
| 03/27/2013 | CN102988326A Febuxostat tablets and preparation method and detection method thereof |
| 03/27/2013 | CN102988320A Capecitabine dispersible tablet and preparation method thereof |
| 03/27/2013 | CN102988319A III crystal form pramipexole hydrochloride tablet and preparation method thereof |
| 03/27/2013 | CN102988318A Orally rapidly disintegrating tablet and process for producing same |
| 03/27/2013 | CN102988316A Efavirenz tablet and preparation method thereof |
| 03/27/2013 | CN102988315A Preparation method of agomelatine solid preparation |
| 03/27/2013 | CN102988314A Lelrozol orally-disintegrating tablet and its preparation method |
| 03/27/2013 | CN102988313A Anastrozole dispersible tablet and preparation method thereof |
| 03/27/2013 | CN102988312A Clopidogrel hydrogen sulfate tablets and preparation method thereof |
| 03/27/2013 | CN102988311A Thrombolytic freeze-dried powder injection and preparation method thereof |
| 03/27/2013 | CN102988310A Application of salvianolic acid A lyophilized powder in preparation of medicine for protecting ischemia brain tissue |
| 03/27/2013 | CN102988309A Application of salvianolic acid A lyophilized powder in preparation of medicine for inhibiting brain tissueneuron damage or death |
| 03/27/2013 | CN102988308A Application of salvianolic acid A lyophilized powder in preparation of medicine for protecting cerebrovascular endothelial cells |
| 03/27/2013 | CN102988306A Medicinal composition containing sodium ozagrel compound |
| 03/27/2013 | CN102988305A Medicinal composition containing meglumine cyclic adenosine monophosphate compound |
| 03/27/2013 | CN102988304A Medicinal composition containing lysine hydrochloride compound |
| 03/27/2013 | CN102988303A Preparation method of polyinosinic acid-polycytidylic acid lyophilized powder injection |
| 03/27/2013 | CN102988301A Preparation method of long-acting sustained-release microspheres containing bevacizumab |
| 03/27/2013 | CN102988299A Formation method of drug coating and drug coating prepared by same |
| 03/27/2013 | CN102988298A Preparation method of sitafloxacin hydrate granule composition |
| 03/27/2013 | CN102988297A Roflumilast solid dispersion and medicinal composition containing same |
| 03/27/2013 | CN102988296A Celecoxib solid dispersion and preparation method thereof |
| 03/27/2013 | CN102988295A Cell-penetrating peptide modified nanoparticle and its preparation method |
| 03/27/2013 | CN102988293A Oxaliplatin folic acid targeted lipidosome and application thereof |
| 03/27/2013 | CN102988292A Gypenoside lipidosome consisting of sterol and preparation method thereof |
| 03/27/2013 | CN102988289A Preparation method for fat-soluble phtosensitizer nanoparticles and application thereof |
| 03/27/2013 | CN102988286A Enrofloxacin injection |
| 03/27/2013 | CN102988285A Docetaxel injection composition and preparation method thereof |
| 03/27/2013 | CN102988284A Preparation method for monosialotetrahexosyl ganglioside sodium injection |
| 03/27/2013 | CN102988282A Preparation method of injection solution for improving weaned piglet intestinal tract development |
| 03/27/2013 | CN102988281A Injection of ambroxol hydrochloride and preparation method thereof |
| 03/27/2013 | CN102988279A Pinocembrin and cyclodextrin supermolecular inclusion complex and preparation method thereof |
| 03/27/2013 | CN102988278A Bromfenac sodium hydrate eye drops and preparation method thereof |
| 03/27/2013 | CN102988277A Ointment for treating dermatoses such as cutaneous wart, onychomycosis and callus |
| 03/27/2013 | CN102988276A Prescription and preparation process of terbinafine hydrochloride cream |
| 03/27/2013 | CN102988275A Carbomer gel and preparation method thereof |
| 03/27/2013 | CN102988274A Sustained-release blood vessel embolic gel used for treating tumor, and preparation method thereof |
| 03/27/2013 | CN102657870B Vaccine cryoprotectant without composition of gelatin and human albumin |
| 03/27/2013 | CN102614159B Ambroxol hydrochloride composition |
| 03/27/2013 | CN102600196B Externally applied medicine composition for treating common acne |
| 03/27/2013 | CN102600153B Pediatric compound anisodamine hydrobromide and chlorpheniramine maleate freeze-dried orally disintegrating tablets and manufacturing method thereof |
| 03/27/2013 | CN102600119B Pediatric acetaminophen composition |
| 03/27/2013 | CN102525979B Infant ibuprofen composition |
| 03/27/2013 | CN102488664B Pharmaceutical composition containing 12 vitamins |
| 03/27/2013 | CN102408561B Segmented copolymer and preparation method thereof, and temperature sensitive type hydrogel |
| 03/27/2013 | CN102397471B Effective and simple method for treating pimples |
| 03/27/2013 | CN102382034B Synthetic method of N-amino-3-azabicyclo[3,3,0]octane hydrochloride |
| 03/27/2013 | CN102336904B Multivalent polyglycol (PEG) modifier for camptothecin and derivatives thereof and application of multivalent PEG modifier |
| 03/27/2013 | CN102335284B Externally applied health care product for recovery of female cauliflower excrescence |
| 03/27/2013 | CN102335155B Quetiapine fumarate sustained-release tablets and preparation method thereof |
| 03/27/2013 | CN102321158B Polypeptide for preventing cell DNA synthesis and inhibiting cell proliferation and application |
| 03/27/2013 | CN102302460B Methylprednisolone sodium succinate freeze dried powder injection and preparation method thereof |
| 03/27/2013 | CN102294035B Dually-targeted anticancer nano-drug delivery system and preparation method thereof |
| 03/27/2013 | CN102274204B Omeprazole enteric-coated capsule and preparation method theroef |
| 03/27/2013 | CN102266323B Composition of ezetimibe and simvastatin and preparation method thereof |
| 03/27/2013 | CN102258548B Method for preparing nardostachyos root and rhizome volatile oil beta-cyclodextrin inclusion compound |
| 03/27/2013 | CN102247604B Angiotensin II receptor 1 type polypeptide-vector vaccine and application thereof |
| 03/27/2013 | CN102247319B Thymalfasin-containing medicinal composition and preparation method thereof |
| 03/27/2013 | CN102232930B Landiolol hydrochloride pharmaceutical compositions and preparation methods thereof |
| 03/27/2013 | CN102218043B LDH (Layered Double Hydroxides) supermolecular assembly type aspirin sustained release tablet and preparation method thereof |
| 03/27/2013 | CN102198276B Application of chylomicron as liver targeting gene treatment vector |
| 03/27/2013 | CN102198098B Temperature-sensitive core-shell vesicle controlled-release drug carrier, preparation method and application thereof |
| 03/27/2013 | CN102188394B Vinflunine freeze-drying medicinal composition |
| 03/27/2013 | CN102166259B Method for preparing biflavone capsules and tablets |
| 03/27/2013 | CN102144964B Stable and safe edaravone injecta |
| 03/27/2013 | CN102133341B Oral cavity nursing agent, preparation method thereof and application thereof |
| 03/27/2013 | CN102133178B Clindamycin phosphate injection and preparation method thereof |
| 03/27/2013 | CN102119925B Protein nano particle with tissue factor targeting property and preparation method and application thereof |
| 03/27/2013 | CN102106807B Method for preparing solid preparation and solid preparation |
| 03/27/2013 | CN102105154B Preparation for oral administration comprising water-extracted chondroitin sulfate and quercetin glycoside |
| 03/27/2013 | CN102070895B Core-shell microcapsule and preparation method thereof |
| 03/27/2013 | CN102000094B Ibandronic acid-containing medicinal composition and preparation process thereof |
| 03/27/2013 | CN101991848B Synthetic peptide vaccine for swine fever and application thereof |
| 03/27/2013 | CN101990442B Modified hydroxypolymer conjugates with bone seeking and tumor killing moieties |
| 03/27/2013 | CN101961314B Novel nanoemulsion drug loading system for protein drugs and preparation method thereof |
| 03/27/2013 | CN101933958B Preparation method of kiwi polyphenol microcapsules |
| 03/27/2013 | CN101932317B 稳定的药物组合物 Stable pharmaceutical compositions |
| 03/27/2013 | CN101912615B Cladribine formulations for improved oral and transmucosal delivery |
| 03/27/2013 | CN101912397B Flupentixol composition |
| 03/27/2013 | CN101890023B Cefuroxime axetil oral liquid and preparation method thereof |
| 03/27/2013 | CN101889993B Surface-modified salbutamol suspension type non-Freon inhalation aerosol and preparation method thereof |
| 03/27/2013 | CN101880656B Agkistrodon halys venom thrombin and preparation method and application thereof |
| 03/27/2013 | CN101854914B Stable formulations of amylin and analogues thereof |
| 03/27/2013 | CN101836987B Compound niacin sustained release tablet |